Modulates inflammation and protects the gastrointestinal tract, aiding in the prevention of ulcers and promoting intestinal healing
Many autistic children are gestalt language learners who rely on scripts and echolalic phrases as part of their communication repertoire
While evidence from genetic studies, meta-analyses, and specific cardiovascular outcome trials (CVOTs) supports an association between certain GLP-1RAs and reduced AF risk, conflicting data exist regarding drug-specific effects, underscoring the need for further mechanistic and outcome research
Reported side effects include: Bloating, gas, abdominal cramps
The number of cases involving glucagon-like peptide-1 (GLP-1) drugs, such as Rybelsus, now totals over 2,100 lawsuits